Brief: Qualigen Therapeutics Initiates Good Laboratory Practice (Glp) Toxicology Studies On Qn-302
Jan 24 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS INITIATES GOOD LABORATORY PRACTICE
(GLP)
TOXICOLOGY STUDIES ON QN-302
* QUALIGEN THERAPEUTICS INC - STUDY WILL BE CONDUCTED BY
WUXI
APPTE
Source text for Eikon: ID:nGNX8bD1zP
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise